IDEXX Laboratories Inc (IDXX) reported better-than-expected financial results for the third quarter of fiscal 2025. The company's earnings per share (EPS) reached $3.40, exceeding Wall Street's consensus estimate of $3.19 by $0.21. Revenue matched expectations at $1.1 billion.
This update provides insight into IDEXX's operational performance and financial health. The company engages in the development, manufacture, and distribution of products and services for the veterinary, livestock, poultry, dairy, and water testing markets. Headquartered in Westbrook, Maine, IDEXX employs approximately 11,000 full-time staff and serves various segments, including the Companion Animal Group, Water quality products, and Livestock, Poultry and Dairy.
IDEXX will host its earnings conference call at 8:00 AM (BMO) to discuss these results and offer additional commentary on business performance. Investors are encouraged to review the full earnings release for a comprehensive understanding of the quarter's performance and future outlook.
The company's financial snapshot reflects a market capitalization of $56.4 billion and a trailing twelve months (TTM) price-to-earnings (P/E) ratio of 54.89. Upcoming earnings are scheduled for August 2, 2026, with an EPS estimate of 3.9821 and revenue estimate of $1.2 billion.